2023
DOI: 10.1007/s00438-023-02042-0
|View full text |Cite
|
Sign up to set email alerts
|

Optimization of mammalian expression vector by cis-regulatory element combinations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 36 publications
0
2
0
Order By: Relevance
“…Different strategies have been used to increase the productivity and quality of protein in CHO expression systems [ 7 , 10 , 13 , 16 ]. Expression vectors are one of key elements that influence recombinant protein yield and quality; thus, optimization of expression vectors can greatly increase transgene expression levels [ 13 , 16 , 17 , 21 ]. The promoter is the main component of the vector expression cassette, and optimization of promoter can improve targeting specificity and gene expression [ 34 , 35 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Different strategies have been used to increase the productivity and quality of protein in CHO expression systems [ 7 , 10 , 13 , 16 ]. Expression vectors are one of key elements that influence recombinant protein yield and quality; thus, optimization of expression vectors can greatly increase transgene expression levels [ 13 , 16 , 17 , 21 ]. The promoter is the main component of the vector expression cassette, and optimization of promoter can improve targeting specificity and gene expression [ 34 , 35 ].…”
Section: Discussionmentioning
confidence: 99%
“…The strong human cytomegalovirus major immediate early gene (CMV) promoter is widely applied to express the GOI in CHO cell system. However, CMV promoter is inherently prone to silencing, leading to drop in yield during long-time expression [ [19] , [20] , [21] , [22] , [23] , [24] ]. The CMV promoter mainly consists of an upstream regulatory sequence (URS), CMV enhancer, core polymerase II promoter, first exon, and intron A [ 25 , 26 ].…”
Section: Introductionmentioning
confidence: 99%